COVID-19 vaccinations make new record as India crosses one-crore mark

-

India administered over one crore COVID-19 vaccine doses on Friday, crossing a new inoculation milestone that was hailed by top Bharatiya Janata Party (BJP) leaders, including Prime Ministee Narendra Modi.

As of 10 pm, 1,00,64,032 vaccine doses were registered with Uttar Pradesh topping the list of states with 28 lakh-plus jabs.

August is India's best month in vaccination coverage; the country has crossed 15 crore doses so far - higher than 13.45 crore doses in July and 11.97 crore doses in June.

"Crossing 1 crore is a momentous feat. Kudos to those getting vaccinated and those making the vaccination drive a success," PM Modi tweeted.

BJP president JP Nadda too lauded the feat.

With this, COVID-19 vaccination coverage in the country has crossed 62 crore (62,09,43,580) doses, according to a provisional report compiled at 7pm. The final report for the day would be compiled by late night, the ministry said earlier in the day.

A total of 23,72,15,353 people in the age group of 18-44 years have received the first dose and 2,45,60,807 have been administered the second dose of the vaccine since the start of the third phase of the vaccination drive, according to the health ministry.

The vaccination exercise - a tool to protect the most vulnerable population groups in the country from COVID-19 - continues to be regularly reviewed and monitored at the highest level, the ministry said.

India, a country of over 130 crore people, began its inoculation drive on January 16, with health care workers getting the shot in the first phase. The net was widened in February to include frontline workers in the list of beneficiaries. In March, all above 60 and the 44+ population with comorbidities became eligible for vaccination. In April, the comorbidity clause was dropped, making all above 44 eligible for the drive. In May, the entire adult population was made eligible for the jabs.

The drive suffered a few hiccups with its pace slowing down in May, even as a brutal second wave of infections triggered an unprecedented shortage of hospital beds and life-saving medical oxygen in the country. Some states alleged that they had to put brakes on the vaccination drive due to shortage of stocks, though the Centre maintained enough vaccines were available in the country.

With inputs from PTI​



from Firstpost India Latest News https://ift.tt/3kyoUWG
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more